Curcumin and Indian gooseberry to feature in new Alzheimer’s trials
Saturday, September 10th, 2011Speaking at a webinar on Alzheimer’s organized by EuroPharma president Terry Lemerond, Professor Ralph Martins said the first trial would examine the effect of a bioavailable form of curcumin – the bioactive component in turmeric – on amyloid accumulation in the human brain.
Original post:
... continue reading